Return to Publications  |  Return to CINJ Home
Rutgers Cancer Institute of New Jersey's Cancer Connection, September 2015
Donate NowThe latest news on research, treatment, prevention and education from the
state's only National Cancer Institute-designated Comprehensive Cancer Center
New Approach to Decades Old Therapy Increases Survival for Some Prostate Cancer Patients

 

DiPaola

Research coordinated by the ECOG-ACRIN Cancer Research Group and published in the August 5 online edition of The New England Journal of Medicine, examines the outcomes of giving the chemotherapy drug docetaxel at the start of androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer. Results showed an increased survival of 13.6 months for patients treated with ADT plus docetaxel than with ADT alone. Rutgers Cancer Institute of New Jersey Director Robert S. DiPaola, MD, is the senior author for this publication and helped lead the design of the protocol a decade ago when he was the national chairman of the ECOG Genitourinary Committee.Learn more

A New Resource for Cancer Survivors

 

transitiona

Cancer Transitions, a free, six-week series of classes designed to support cancer survivors, is coming to Rutgers Cancer Institute beginning October 1 and running through November 5. Provided by the Cancer Support Community of Central New Jersey, the program assists survivors with relaxation, stress management, nutrition and more. The program is open to those who have completed active treatment within the past month to two years and currently have no signs of cancer.Learn more

Exploring the Use of Aspirin and a Diabetes Drug for Prostate Cancer Prevention and Control

 

Tan

Rutgers Cancer Institute of New Jersey researcher XiangLin Tan, MD, PhD, has been awarded an $852,705 Career Development Award from the National Cancer Institute to explore the use of aspirin and a diabetes drug for prostate cancer prevention and control. Dr. Tan, who is also an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School and an assistant professor of epidemiology at Rutgers School of Public Health, will examine the insulin-lowering effects of metformin and the anti-inflammatory properties of aspirin to see if the combination will prevent or delay the progression of prostate cancer.Learn more

Cox Classic Charity Golf Outing to Support Rutgers Cancer Institute

 

Cox

Registration is now open for the 26th Annual Steven A. Cox Charity Classic, which will benefit Rutgers Cancer Institute of New Jersey. Through the years, the event has raised some $6.5 million - a portion of which has supported various programs at Rutgers Cancer Institute, including the Prostate Cancer Program, the LIFE (LPGA pros In the Fight to Eradicate breast cancer) Center, and the Steven A. Cox Scholarship in Cancer Research. The event will be held October 5 at New Jersey National Golf Club in Basking Ridge, New Jersey.Learn more

A Reminder during this National Childhood Cancer Awareness Month

 

Drachtman

As fall kicks in and it's back to regular routines with school, sports and clubs for the kids, don't forget to schedule your child for a regular check-up with their pediatrician. Along with monitoring overall health and wellness, this routine visit can serve as a preventative tool in helping to combat conditions such as obesity, heart disease and even cancer. Rutgers Cancer Institute of New Jersey's Richard Drachtman, MD, section chief of pediatric hematology-oncology and professor of pediatrics at Rutgers Robert Wood Johnson Medical School, shares some insight.Learn more

            Rutgers Cancer Institute of New Jersey                                          NCI logo 

Office of Communications         ·         www.cinj.org        ·        732-235-9871

                        Like us on Facebook                     Join the CINJ Mailing List